Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Patrick Fourteau currently holds 27,779 shares of Insys Therapeutics, Inc. (INSY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Patrick Fourteau has been a net seller of INSY stock. They have purchased $816.6K and sold $20.5M worth of shares.
Patrick Fourteau's most recent insider trade was on Jan 31, 2018, when they sold 27,779 shares at $0.67 per share.
Patrick Fourteau serves as Executive at Insys Therapeutics, Inc. (INSY). They have executed 46 insider transactions totaling $21.3M over their tenure at the company.
Patrick Fourteau holds the position of Executive at Insys Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
Patrick Fourteau has shown a selling trading pattern, with $816.6K in total purchases and $20.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Patrick Fourteau was on Dec 5, 2007, when they purchased $2.7M worth of SCRX shares. This transaction involved 123,000 shares at $22.00 per share.
Patrick Fourteau currently owns 27,779 shares of Insys Therapeutics, Inc. (INSY), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Patrick Fourteau's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Patrick Fourteau has 46 Form 4 filings on record as an insider at Insys Therapeutics, Inc..
Set alerts for Patrick Fourteau and 40,000+ other insiders.